A detailed history of Nicholas Investment Partners, LP transactions in Insmed Inc stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 101,145 shares of INSM stock, worth $7.08 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
101,145
Previous 74,871 35.09%
Holding current value
$7.08 Million
Previous $5.02 Million 47.19%
% of portfolio
0.82%
Previous 0.59%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $1.63 Million - $2.08 Million
26,274 Added 35.09%
101,145 $7.38 Million
Q2 2024

Aug 07, 2024

BUY
$22.0 - $69.71 $1.65 Million - $5.22 Million
74,871 New
74,871 $5.02 Million
Q3 2019

Nov 13, 2019

SELL
$15.49 - $25.78 $2.43 Million - $4.05 Million
-157,016 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$23.0 - $32.19 $766,452 - $1.07 Million
33,324 Added 26.94%
157,016 $4.02 Million
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $1.72 Million - $3.85 Million
123,692 New
123,692 $3.6 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.